| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_717c792fca7cc9c290c9db33e8fe078b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2517-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2015-8518
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-101
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-01 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8771
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8509
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61D19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0273 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-16 |
| filingDate |
2003-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bff742b0c1d4ef97e1375aa931baf133
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1a36904b9bac73a61221dba6eb40eb5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc381fc4232a6ab3a0bd3449345e0450
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fd5da3e01b9bc3b76622798654859b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_150465b61d5937880b4a5afe7b6b072e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17c896885b6da28027afe4691709e70e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_608f746a0e423716857e48ef24292c19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_475809adbc5849d1831fc6f25e7d2957
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37bf90752cd5a12d6024e82dabf80671 |
| publicationDate |
2004-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20040101793-A |
| titleOfInvention |
Transgenic cloned cow producing human erythropoietin and method for producing the same |
| abstract |
The present invention comprises the steps of introducing and targeting a gene expressing human erythropoietin (hEPO) to somatic cells derived from mature cattle; Method for producing a transgenic clone comprising the step of producing a clone using the somatic cells introduced and hit the foreign gene expressing the hEPO and transgenic clone expressing the EPO produced by such a method It is about.n n n The present invention also relates to a method of introducing and targeting a gene expressing hEPO into somatic cells of a mature bovine and producing hEPO from the mammary gland of a clone produced using the transformed somatic cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9738694-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010535496-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009020252-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8420388-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100769291-B1 |
| priorityDate |
2003-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |